Health News

Alunbrig

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ALUNBRIG CMI AU VERSION 1.0 This medicine is subject to additional monitoring. This will allow quick identificationof new safety information. You can help by reporting any side effects you may get.You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems. […]

Health News

Tarceva

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TARCEVA CMI 190301 Film-Coated Tablets pronounced “tar-see-va” contains the active ingredient erlotinib Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Tarceva tablets. It does not contain all the available information. It does not take the […]

Health News

Opdivo

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OPDIVO CMI _V17.0 (op-DEE-voh) Nivolumab (nee-vol-u-mab) Consumer Medicine Information WARNINGS AND PRECAUTIONS – COMBINATION OF OPDIVO AND IPILIMUMAB Both OPDIVO and ipilimumab act on your immune system and may cause inflammation in parts of your body. Inflammation may cause serious damage to […]